ClearBridge Investments’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-4,050
| Closed | -$476K | – | 750 |
|
2022
Q2 | $476K | Hold |
4,050
| – | – | ﹤0.01% | 717 |
|
2022
Q1 | $528K | Hold |
4,050
| – | – | ﹤0.01% | 732 |
|
2021
Q4 | $618K | Hold |
4,050
| – | – | ﹤0.01% | 732 |
|
2021
Q3 | $655K | Hold |
4,050
| – | – | ﹤0.01% | 723 |
|
2021
Q2 | $663K | Hold |
4,050
| – | – | ﹤0.01% | 747 |
|
2021
Q1 | $610K | Sell |
4,050
-25
| -0.6% | -$3.77K | ﹤0.01% | 736 |
|
2020
Q4 | $617K | Buy |
4,075
+1,050
| +35% | +$159K | ﹤0.01% | 702 |
|
2020
Q3 | $410K | Hold |
3,025
| – | – | ﹤0.01% | 712 |
|
2020
Q2 | $413K | Sell |
3,025
-3,300
| -52% | -$451K | ﹤0.01% | 674 |
|
2020
Q1 | $681K | Buy |
6,325
+300
| +5% | +$32.3K | ﹤0.01% | 638 |
|
2019
Q4 | $722K | Buy |
6,025
+200
| +3% | +$24K | ﹤0.01% | 668 |
|
2019
Q3 | $580K | Buy |
5,825
+100
| +2% | +$9.96K | ﹤0.01% | 687 |
|
2019
Q2 | $625K | Buy |
5,725
+500
| +10% | +$54.6K | ﹤0.01% | 686 |
|
2019
Q1 | $584K | Buy |
5,225
+4,875
| +1,393% | +$545K | ﹤0.01% | 698 |
|
2018
Q4 | $34K | Hold |
350
| – | – | ﹤0.01% | 897 |
|
2018
Q3 | $43K | Buy |
+350
| New | +$43K | ﹤0.01% | 922 |
|
2017
Q4 | – | Sell |
-30
| Closed | -$3K | – | 1198 |
|
2017
Q3 | $3K | Buy |
+30
| New | +$3K | ﹤0.01% | 1141 |
|
2014
Q1 | – | Sell |
-59,250
| Closed | -$4.48M | – | 1135 |
|
2013
Q4 | $4.48M | Hold |
59,250
| – | – | 0.01% | 591 |
|
2013
Q3 | $4.14M | Hold |
59,250
| – | – | 0.01% | 580 |
|
2013
Q2 | $3.44M | Buy |
+59,250
| New | +$3.44M | 0.01% | 586 |
|